[
  {
    "icdCode": "A09",
    "nameEn": "Acute Gastroenteritis",
    "nameAr": "التهاب المعدة والأمعاء الحاد",
    "localName": "إسهال حاد",
    "category": "infectious",
    "prevalenceIraq": "high",
    "description": "Inflammation of the stomach and intestines, typically caused by viral or bacterial infection, leading to diarrhea and vomiting. Very common in Iraq due to water quality issues and food hygiene challenges.",
    "symptoms": [1, 2, 3, 4, 5],
    "riskFactors": ["Contaminated water", "Poor food hygiene", "Crowded living conditions", "Lack of sanitation", "Hot climate"],
    "complications": ["Dehydration", "Electrolyte imbalance", "Malnutrition", "Sepsis (severe cases)"],
    "differentialDiagnosis": ["A00", "A02.0", "K52.9"],
    "redFlags": [1, 2, 3],
    "treatmentProtocol": {
      "immediate": ["Oral rehydration solution (ORS)", "Zinc supplementation for children"],
      "medications": ["Antiemetics if needed", "Antibiotics only if bacterial confirmed"],
      "monitoring": ["Hydration status", "Urine output", "Vital signs"],
      "referral": "If severe dehydration, bloody diarrhea, or high fever persists >48 hours"
    },
    "prognosis": "Excellent with proper hydration. Most cases resolve in 3-7 days.",
    "preventionMeasures": ["Safe drinking water", "Hand washing", "Food safety", "Proper sanitation"],
    "specialConsiderations": "In Iraq, consider cholera during outbreaks. Rotavirus vaccination recommended for children."
  },
  {
    "icdCode": "E11",
    "nameEn": "Type 2 Diabetes Mellitus",
    "nameAr": "داء السكري من النوع الثاني",
    "localName": "مرض السكر",
    "category": "chronic",
    "prevalenceIraq": "high",
    "description": "Chronic metabolic disorder characterized by insulin resistance and relative insulin deficiency. Prevalence increasing rapidly in Iraq due to lifestyle changes, obesity, and dietary factors.",
    "symptoms": [10, 11, 12, 13, 14],
    "riskFactors": ["Obesity", "Family history", "Sedentary lifestyle", "Age >40", "High carbohydrate diet", "Hypertension"],
    "complications": ["Diabetic retinopathy", "Diabetic nephropathy", "Diabetic neuropathy", "Cardiovascular disease", "Diabetic foot", "Stroke"],
    "differentialDiagnosis": ["E10", "E13", "R73.9"],
    "redFlags": [4, 5, 6],
    "treatmentProtocol": {
      "lifestyle": ["Diet modification (reduce refined carbs, increase fiber)", "Regular exercise (30 min/day)", "Weight loss if overweight"],
      "medications": ["Metformin (first-line)", "Sulfonylureas", "DPP-4 inhibitors", "Insulin (if needed)"],
      "monitoring": ["HbA1c every 3 months", "Fasting blood glucose", "Blood pressure", "Lipid profile", "Kidney function", "Eye examination annually"],
      "targets": "HbA1c <7%, FBG 80-130 mg/dL, BP <140/90"
    },
    "prognosis": "Chronic condition requiring lifelong management. Good control prevents complications.",
    "preventionMeasures": ["Maintain healthy weight", "Regular physical activity", "Balanced diet", "Regular screening if high risk"],
    "specialConsiderations": "In Iraq, access to medications and monitoring may be limited. Emphasize dietary control and affordable generic medications. Ramadan fasting requires special management."
  },
  {
    "icdCode": "I10",
    "nameEn": "Essential Hypertension",
    "nameAr": "ارتفاع ضغط الدم الأساسي",
    "localName": "ضغط الدم",
    "category": "chronic",
    "prevalenceIraq": "high",
    "description": "Persistently elevated blood pressure (≥140/90 mmHg) without identifiable cause. Very common in Iraq, often undiagnosed and undertreated.",
    "symptoms": [15, 16, 17, 18],
    "riskFactors": ["Age", "Family history", "Obesity", "High salt diet", "Sedentary lifestyle", "Stress", "Smoking"],
    "complications": ["Stroke", "Myocardial infarction", "Heart failure", "Chronic kidney disease", "Retinopathy"],
    "differentialDiagnosis": ["I15.0", "I15.1", "I15.2"],
    "redFlags": [7, 8, 9],
    "treatmentProtocol": {
      "lifestyle": ["Low salt diet (<5g/day)", "DASH diet", "Weight loss", "Regular exercise", "Limit alcohol", "Stress management"],
      "medications": ["ACE inhibitors/ARBs (first-line)", "Calcium channel blockers", "Diuretics", "Beta-blockers (if indicated)"],
      "monitoring": ["Home BP monitoring", "Clinic BP every 1-3 months", "Annual kidney function and electrolytes", "Annual ECG"],
      "targets": "BP <140/90 mmHg (or <130/80 if diabetes/CKD)"
    },
    "prognosis": "Excellent if well-controlled. Reduces cardiovascular risk by 30-40%.",
    "preventionMeasures": ["Healthy diet", "Regular exercise", "Maintain normal weight", "Limit salt intake", "Avoid smoking"],
    "specialConsiderations": "In Iraq, medication adherence is challenging due to cost. Emphasize lifestyle modifications and use affordable generic medications."
  },
  {
    "icdCode": "J45",
    "nameEn": "Asthma",
    "nameAr": "الربو",
    "localName": "حساسية الصدر",
    "category": "chronic",
    "prevalenceIraq": "medium",
    "description": "Chronic inflammatory airway disease causing reversible airflow obstruction. Prevalence increasing in Iraq, especially in urban areas due to air pollution and dust storms.",
    "symptoms": [20, 21, 22, 23, 24],
    "riskFactors": ["Family history", "Allergies", "Air pollution", "Dust exposure", "Smoking", "Respiratory infections in childhood"],
    "complications": ["Acute exacerbation", "Respiratory failure", "Status asthmaticus", "Pneumothorax", "Chronic airway remodeling"],
    "differentialDiagnosis": ["J44", "J20", "J21"],
    "redFlags": [10, 11, 12],
    "treatmentProtocol": {
      "controller": ["Inhaled corticosteroids (ICS) - first-line", "ICS + LABA (if not controlled)", "Leukotriene modifiers"],
      "reliever": ["Short-acting beta-agonists (SABA) - as needed"],
      "severe": ["Oral corticosteroids", "Omalizumab (if allergic)", "Theophylline"],
      "monitoring": ["Peak flow monitoring", "Symptom diary", "Spirometry annually", "Inhaler technique check"],
      "action_plan": "Green-Yellow-Red zone system for self-management"
    },
    "prognosis": "Good control achievable in most patients. Some may outgrow in childhood.",
    "preventionMeasures": ["Avoid triggers", "Dust control", "Air quality awareness", "Smoking cessation", "Flu vaccination"],
    "specialConsiderations": "In Iraq, dust storms are major triggers. Inhaler availability and cost may be barriers. Teach proper inhaler technique. Consider spacer devices."
  },
  {
    "icdCode": "J18.9",
    "nameEn": "Pneumonia",
    "nameAr": "الالتهاب الرئوي",
    "localName": "التهاب الرئة",
    "category": "infectious",
    "prevalenceIraq": "medium",
    "description": "Acute infection of the lung parenchyma, commonly bacterial or viral. Significant cause of morbidity and mortality in Iraq, especially in children and elderly.",
    "symptoms": [25, 26, 27, 28, 29],
    "riskFactors": ["Age <5 or >65", "Smoking", "Chronic lung disease", "Immunosuppression", "Malnutrition", "Crowded living"],
    "complications": ["Respiratory failure", "Sepsis", "Pleural effusion", "Empyema", "Lung abscess", "Death"],
    "differentialDiagnosis": ["J20", "J40", "A15"],
    "redFlags": [13, 14, 15],
    "treatmentProtocol": {
      "outpatient": ["Amoxicillin or Macrolide", "Supportive care", "Hydration", "Antipyretics"],
      "inpatient": ["IV antibiotics (Ceftriaxone + Azithromycin)", "Oxygen therapy", "IV fluids", "Monitoring"],
      "severe": ["ICU admission", "Broad-spectrum antibiotics", "Mechanical ventilation if needed"],
      "duration": "5-7 days (uncomplicated), 7-14 days (complicated)",
      "followup": "Chest X-ray in 6 weeks if >50 years or smoker"
    },
    "prognosis": "Good if treated early. Mortality higher in elderly and immunocompromised.",
    "preventionMeasures": ["Pneumococcal vaccination", "Influenza vaccination", "Smoking cessation", "Hand hygiene", "Avoid crowding"],
    "specialConsiderations": "In Iraq, consider TB in non-resolving pneumonia. Antibiotic resistance is increasing. Consider local resistance patterns."
  },
  {
    "icdCode": "A15",
    "nameEn": "Tuberculosis",
    "nameAr": "السل الرئوي",
    "localName": "مرض السل",
    "category": "infectious",
    "prevalenceIraq": "medium",
    "description": "Chronic bacterial infection caused by Mycobacterium tuberculosis, primarily affecting lungs. Significant public health concern in Iraq, especially in conflict-affected areas.",
    "symptoms": [30, 31, 32, 33, 34],
    "riskFactors": ["Close contact with TB patient", "HIV/AIDS", "Malnutrition", "Crowded living", "Immunosuppression", "Diabetes", "Smoking"],
    "complications": ["Miliary TB", "TB meningitis", "Pleural effusion", "Respiratory failure", "Death", "MDR-TB"],
    "differentialDiagnosis": ["J18.9", "C34", "J44"],
    "redFlags": [16, 17, 18],
    "treatmentProtocol": {
      "intensive_phase": ["Rifampicin + Isoniazid + Pyrazinamide + Ethambutol for 2 months"],
      "continuation_phase": ["Rifampicin + Isoniazid for 4 months"],
      "monitoring": ["Sputum smear at 2, 5, 6 months", "Liver function tests", "Visual acuity (Ethambutol)", "Adherence support"],
      "dots": "Directly Observed Treatment Short-course (DOTS) strategy",
      "contacts": "Screen and treat household contacts"
    },
    "prognosis": "Curable with proper treatment. Relapse risk if incomplete treatment. MDR-TB has poorer prognosis.",
    "preventionMeasures": ["BCG vaccination", "Contact tracing", "Infection control", "Treat latent TB in high-risk", "Improve living conditions"],
    "specialConsiderations": "In Iraq, DOTS program available through MOH. Free treatment. MDR-TB increasing. Ensure adherence through community support. Consider TB in any chronic cough >2 weeks."
  },
  {
    "icdCode": "K29.7",
    "nameEn": "Chronic Gastritis",
    "nameAr": "التهاب المعدة المزمن",
    "localName": "التهاب المعدة",
    "category": "chronic",
    "prevalenceIraq": "high",
    "description": "Chronic inflammation of the gastric mucosa, often associated with H. pylori infection. Very common in Iraq due to high H. pylori prevalence.",
    "symptoms": [35, 36, 37, 38],
    "riskFactors": ["H. pylori infection", "NSAIDs use", "Alcohol", "Smoking", "Stress", "Autoimmune conditions"],
    "complications": ["Peptic ulcer", "Gastric bleeding", "Gastric cancer (long-term)", "Vitamin B12 deficiency"],
    "differentialDiagnosis": ["K25", "K21.9", "C16"],
    "redFlags": [19, 20, 21],
    "treatmentProtocol": {
      "h_pylori_eradication": ["Triple therapy: PPI + Amoxicillin + Clarithromycin for 14 days", "Or Quadruple therapy if resistance suspected"],
      "symptomatic": ["Proton pump inhibitors (PPIs)", "H2 receptor antagonists", "Antacids"],
      "lifestyle": ["Avoid NSAIDs", "Reduce alcohol", "Quit smoking", "Stress management", "Avoid trigger foods"],
      "testing": ["H. pylori testing (stool antigen or breath test)", "Endoscopy if alarm symptoms"]
    },
    "prognosis": "Good with H. pylori eradication. Symptoms improve in 2-4 weeks.",
    "preventionMeasures": ["H. pylori eradication", "Avoid NSAIDs", "Healthy diet", "Stress management"],
    "specialConsiderations": "In Iraq, H. pylori prevalence is very high (>70%). Consider empiric treatment if testing unavailable. Clarithromycin resistance increasing - may need quadruple therapy."
  },
  {
    "icdCode": "N39.0",
    "nameEn": "Urinary Tract Infection",
    "nameAr": "التهاب المسالك البولية",
    "localName": "التهاب البول",
    "category": "infectious",
    "prevalenceIraq": "high",
    "description": "Bacterial infection of the urinary system, most commonly bladder (cystitis). Very common in Iraq, especially in women, due to hygiene challenges and water scarcity.",
    "symptoms": [40, 41, 42, 43, 44],
    "riskFactors": ["Female gender", "Sexual activity", "Pregnancy", "Diabetes", "Urinary catheter", "Kidney stones", "Poor hygiene"],
    "complications": ["Pyelonephritis", "Sepsis", "Chronic kidney disease", "Recurrent infections"],
    "differentialDiagnosis": ["N10", "N30.0", "N34.1"],
    "redFlags": [22, 23, 24],
    "treatmentProtocol": {
      "uncomplicated": ["Nitrofurantoin 5-7 days", "Or Trimethoprim-sulfamethoxazole 3 days", "Or Fosfomycin single dose"],
      "complicated": ["Ciprofloxacin 7-14 days", "Or Ceftriaxone if severe"],
      "supportive": ["Increased fluid intake", "Urinary analgesics (Phenazopyridine)", "Avoid bladder irritants"],
      "followup": "Urine culture if symptoms persist or recurrent infections"
    },
    "prognosis": "Excellent with appropriate antibiotics. Symptoms improve in 24-48 hours.",
    "preventionMeasures": ["Adequate hydration", "Urinate after intercourse", "Wipe front to back", "Avoid holding urine", "Cranberry products may help"],
    "specialConsiderations": "In Iraq, antibiotic resistance is increasing. Consider local resistance patterns. Recurrent UTIs common due to water scarcity. Emphasize hydration."
  },
  {
    "icdCode": "M19.9",
    "nameEn": "Osteoarthritis",
    "nameAr": "التهاب المفاصل التنكسي",
    "localName": "خشونة المفاصل",
    "category": "chronic",
    "prevalenceIraq": "medium",
    "description": "Degenerative joint disease characterized by cartilage breakdown and joint pain. Common in Iraq, especially in elderly and those with obesity or previous joint injuries.",
    "symptoms": [45, 46, 47, 48],
    "riskFactors": ["Age >50", "Obesity", "Previous joint injury", "Repetitive joint stress", "Family history", "Female gender"],
    "complications": ["Chronic pain", "Disability", "Reduced mobility", "Depression", "Falls in elderly"],
    "differentialDiagnosis": ["M05", "M10", "M15"],
    "redFlags": [25, 26],
    "treatmentProtocol": {
      "non_pharmacological": ["Weight loss", "Physical therapy", "Exercise (low-impact)", "Joint protection", "Assistive devices"],
      "pharmacological": ["Paracetamol (first-line)", "NSAIDs (topical or oral)", "Intra-articular corticosteroids", "Hyaluronic acid injections"],
      "surgical": ["Joint replacement if severe and refractory"],
      "monitoring": ["Pain assessment", "Functional status", "Side effects of medications"]
    },
    "prognosis": "Progressive condition. Symptoms can be managed but not cured. Joint replacement very effective for severe cases.",
    "preventionMeasures": ["Maintain healthy weight", "Regular exercise", "Avoid joint injuries", "Proper ergonomics"],
    "specialConsiderations": "In Iraq, access to joint replacement surgery limited. Emphasize weight loss and physical therapy. NSAIDs widely used but monitor for GI side effects."
  },
  {
    "icdCode": "E66.9",
    "nameEn": "Obesity",
    "nameAr": "السمنة",
    "localName": "الوزن الزائد",
    "category": "chronic",
    "prevalenceIraq": "high",
    "description": "Excessive body fat accumulation (BMI ≥30 kg/m²) that presents health risks. Rapidly increasing in Iraq due to dietary changes, sedentary lifestyle, and urbanization.",
    "symptoms": [50, 51, 52],
    "riskFactors": ["High-calorie diet", "Sedentary lifestyle", "Genetic factors", "Metabolic disorders", "Medications", "Psychological factors"],
    "complications": ["Type 2 diabetes", "Hypertension", "Cardiovascular disease", "Osteoarthritis", "Sleep apnea", "Fatty liver", "Certain cancers"],
    "differentialDiagnosis": ["E27.0", "E03.9", "E24.9"],
    "redFlags": [27, 28],
    "treatmentProtocol": {
      "lifestyle": ["Calorie-restricted diet (500-1000 kcal deficit)", "Increase physical activity (150 min/week)", "Behavioral therapy", "Sleep hygiene"],
      "pharmacological": ["Orlistat", "Liraglutide (if diabetic)", "Phentermine (short-term)"],
      "surgical": ["Bariatric surgery if BMI >40 or >35 with comorbidities"],
      "targets": "5-10% weight loss in 6 months",
      "monitoring": ["Weight", "BMI", "Waist circumference", "Comorbidities", "Nutritional status"]
    },
    "prognosis": "Weight loss improves health outcomes. Requires long-term lifestyle changes. High relapse rate.",
    "preventionMeasures": ["Healthy diet", "Regular physical activity", "Limit sugary drinks", "Portion control", "Family involvement"],
    "specialConsiderations": "In Iraq, cultural factors promote high-calorie foods and large portions. Address cultural beliefs. Bariatric surgery limited availability. Focus on dietary modification and physical activity."
  }
]
